Query: Designing robust high-throughput phenotypic screening platforms for CMT cell models: assay miniaturization, reproducibility metrics, Zâ€™-factor optimization, integration of multi-parametric imaging, label-free sensors, electrophysiological endpoints, and data analysis workflows for hit identification.

No answer generated.

References:
